Mediterranean Diet, Exercise and Dementia Risk in UK Adults
MedEx-UK
A Randomised Controlled Trial Investigating the Feasibility of a Multi-domain Intervention to Increase Mediterranean Diet (MedDiet) Score and Physical Activity (PA) of Older UK Adults Who Are at Above Average Risk of Dementia
1 other identifier
interventional
108
1 country
3
Brief Summary
In cohort studies, a Mediterranean Dietary Pattern (MDP) has been consistently associated with reduced dementia incidence. The efficacy of a MDP to prevent dementia has never been directly demonstrated by RCTs, with existing research limited to cognition as a secondary outcome. Furthermore, despite their likely additive effects, the combined impact of Physical Activity (PA) and a MDP on dementia risk is unknown. MedEx-UK is a RCT that will evaluate the feasibility of a multi-domain intervention to increase Mediterranean Dietary Pattern (MDP) adherence and physical activity (PA) in a group of older UK adults who are at above average risk of dementia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2018
CompletedFirst Posted
Study publicly available on registry
September 17, 2018
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2023
CompletedDecember 21, 2023
August 1, 2018
1.9 years
August 17, 2018
December 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Increase in MDP using the 14-point MEDAS scale
The extent to which the Mediterranean Dietary Pattern has improved, the target being an increase in 3 points of a 14-point scale, as assessed by Dietary Recall software (Intake 24) and a validated questionnaire (14-point MEDAS)
24 weeks
Increase in PA using activity monitors
The extent to which Physical Activity levels have increased, the target being 150 minutes of moderate activity per week, assessed using an activity monitor worn by participants throughout the 24 week intervention period
24 weeks
Secondary Outcomes (7)
Cognition
24 weeks
Neuroimaging
24 weeks
Vascular function
24 weeks
QRISK3 score
24 weeks
Blood pressure
24 weeks
- +2 more secondary outcomes
Study Arms (3)
MDP only
EXPERIMENTALParticipants will be asked to increase their consumption of foods that are consistent with a Mediterranean Dietary Pattern through interaction with the online LEAP2 platform
MDP plus PA
EXPERIMENTALParticipants will be asked to increase their consumption of foods that are consistent with a Mediterranean Dietary Pattern AND to increase Physical Activity using a mixture of structured and non-structured activities through interaction with the online LEAP2 platform
Control
PLACEBO COMPARATORParticipants will be given generic healthy eating advice based on the NHS 'Eatwell' plate and British Heart Foundation (BHF) guidelines
Interventions
We aim to increase MDP by 3 points, according to a 14-point MEDAS score
Eligibility Criteria
You may qualify if:
- Male and female, aged 55-74 years
- Understands and is willing and able to comply with all study procedures, including changes to diet and physical activity levels
- Access to, and able to use, the internet/computer/tablet device
- QRISK3 score of \>=15 (assessed by GP)
- Subjective Memory Complaints (SMC), based on a score of \>16 on the Cognitive Change Index (CCI) (from the first 12 items)
- Stable use of any prescribed medication for at least four weeks
- Normal (or corrected to normal) vision and hearing
- Fluent in written and spoken English
- Willing and able to provide written informed consent
You may not qualify if:
- Diagnosis of Alzheimer's disease (AD), other form of dementia, Mild Cognitive Impairment (MCI), or significant neurological disorder
- Cognition not within normal range, based on a score of \<26 on the Montreal Cognitive Assessment (MoCA); or an indication of cognitive decline, based on a score of ≥2 on Ascertain Dementia (AD-8)
- Evidence of impairment of Instrumental Activities of Daily living (IADLS)
- Current psychotic illness (delusional disorder/schizophrenia)
- History of serious mental illness know to affect cognition (schizophrenia, schizoaffective disorder, bipolar disorder)
- Subjects with other clinically diagnosed psychiatric disorders likely to affect the cognitive measures (as judged by a clinical advisor)
- HIV positive
- Past history or previous MRI evidence of brain damage, significant head trauma (including loss of consciousness as a result), brain surgery, stroke, or serious neurological disorders
- History of alcohol or drug dependency in the last 2 years
- Subjects with existing diagnosed gastrointestinal disorders likely to impact study results (as judged by a clinical advisor)
- History of any major cardiovascular event, such as a myocardial infarction, stroke or TIA
- Diagnosed COPD
- Cancer, or cancer/treatment within the last 12 months
- Diagnosis of type 1 or type 2 diabetes \< 3 months ago
- Clinical diagnosis of liver or kidney disease
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University of Birmingham
Birmingham, B15 2TT, United Kingdom
Newcastle University
Newcastle upon Tyne, NE2 4HH, United Kingdom
University of East Anglia
Norwich, NR4 7UQ, United Kingdom
Related Publications (3)
Jennings A, Shannon OM, Gillings R, Lee V, Elsworthy R, Bundy R, Rao G, Hanson S, Hardeman W, Paddick SM, Siervo M, Aldred S, Mathers JC, Hornberger M, Minihane AM. Effectiveness and feasibility of a theory-informed intervention to improve Mediterranean diet adherence, physical activity and cognition in older adults at risk of dementia: the MedEx-UK randomised controlled trial. BMC Med. 2024 Dec 23;22(1):600. doi: 10.1186/s12916-024-03815-z.
PMID: 39716203DERIVEDElsworthy RJ, Jong ST, Hanson S, Shannon OM, Jennings A, Gillings R, Siervo M, Hornberger M, Hardeman W, Mathers JC, Minihane AM, Aldred S. Effects of the COVID-19 associated United Kingdom lockdown on physical activity in older adults at high risk of cardiovascular disease: a mixed methods perspective from the MedEx-UK multicenter trial. Front Public Health. 2024 May 9;12:1371453. doi: 10.3389/fpubh.2024.1371453. eCollection 2024.
PMID: 38784572DERIVEDShannon OM, Lee V, Bundy R, Gillings R, Jennings A, Stephan B, Hornberger M, Balanos G, Paddick SM, Hanson S, Hardeman W, Holmes R, Garner N, Aldred S, Siervo M, Mathers JC, Minihane AM. Feasibility and acceptability of a multi-domain intervention to increase Mediterranean diet adherence and physical activity in older UK adults at risk of dementia: protocol for the MedEx-UK randomised controlled trial. BMJ Open. 2021 Feb 5;11(2):e042823. doi: 10.1136/bmjopen-2020-042823.
PMID: 33550254DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Marie Minihane, PhD
University of East Anglia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2018
First Posted
September 17, 2018
Study Start
April 1, 2019
Primary Completion
February 26, 2021
Study Completion
September 7, 2023
Last Updated
December 21, 2023
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share